Posted on 8/9/19
Soligenix: High Risk, High Reward
Summary Soligenix is a small biotech company with just ~$20M market cap. In the near future, the company will complete two Phase 3 trials for its . . .
Summary Soligenix is a small biotech company with just ~$20M market cap. In the near future, the company will complete two Phase 3 trials for its . . .